Home > Qtrly Results > ZYDUS LIFESCIENCES

ZYDUS LIFESCIENCES
Quarterly Results Analysis [Dec2024]

ZYDUS LIFESCIENCES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for ZYDUS LIFESCIENCES
Please provide your vote to see the results

ZYDUS LIFESCIENCES Quarterly Results

Consolidated Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Revenues ₹5,269 Cr ₹5,237 Cr ₹6,208 Cr ₹5,534 Cr ₹4,505 Cr ₹4,369 Cr ₹5,140 Cr ₹5,011 Cr
Expenses ₹3,882 Cr ₹3,821 Cr ₹4,124 Cr ₹3,909 Cr ₹3,403 Cr ₹3,305 Cr ₹3,634 Cr ₹3,755 Cr
Operating Income ₹1,388 Cr ₹1,416 Cr ₹2,084 Cr ₹1,625 Cr ₹1,102 Cr ₹1,064 Cr ₹1,505 Cr ₹1,256 Cr
Other Income ₹58 Cr ₹114 Cr ₹63 Cr ₹162 Cr ₹38 Cr ₹136 Cr ₹36 Cr ₹38 Cr
Interest ₹32 Cr ₹25 Cr ₹32 Cr ₹35 Cr ₹20 Cr ₹9 Cr ₹18 Cr ₹28 Cr
Depreciation ₹229 Cr ₹234 Cr ₹215 Cr ₹205 Cr ₹195 Cr ₹184 Cr ₹180 Cr ₹179 Cr
Profit Before Tax ₹1,184 Cr ₹1,271 Cr ₹1,900 Cr ₹1,547 Cr ₹926 Cr ₹1,007 Cr ₹1,329 Cr ₹486 Cr
Profit After Tax ₹1,005 Cr ₹898 Cr ₹1,464 Cr ₹1,226 Cr ₹712 Cr ₹781 Cr ₹1,113 Cr ₹349 Cr
EPS ₹10.17 ₹9.06 ₹14.11 ₹11.75 ₹7.80 ₹7.91 ₹10.74 ₹2.93
Industry Peers & Returns1W1M1Y
ZYDUS LIFESCIENCES 3.2% -1% 27.4%
SUN PHARMACEUTICAL INDUSTRIES 0.6% -2.1% 16.5%
CIPLA 3.6% 0.2% 2.3%
DR REDDYS LABORATORIES 3% -8.4% 0%
DIVIS LABORATORIES 4.3% 6.5% 63.9%
MANKIND PHARMA -2.5% -8% 16.5%
TORRENT PHARMACEUTICALS 2.9% -0.5% 19.4%
LUPIN 8.2% 0.4% 37%
AUROBINDO PHARMA 5.8% -0.7% 19.5%

ZYDUS LIFESCIENCES Quarterly Revenues

Revenues
Q-o-Q

0.61 %

Y-o-Y

16.96 %

Quarters Revenues % Change
Dec2024 ₹5,269 Cr
0.61
Sep2024 ₹5,237 Cr
-15.63
Jun2024 ₹6,208 Cr
12.17
Mar2024 ₹5,534 Cr
22.83
Dec2023 ₹4,505 Cr
3.12
Sep2023 ₹4,369 Cr
-15.00
Jun2023 ₹5,140 Cr
2.57
Mar2023 ₹5,011 Cr -

ZYDUS LIFESCIENCES Quarterly Operating Profit

Operating Profit
Q-o-Q

-2.01 %

Y-o-Y

25.87 %

Quarters Operating Profit % Change
Dec2024 ₹1,388 Cr
-2.01
Sep2024 ₹1,416 Cr
-32.05
Jun2024 ₹2,084 Cr
28.23
Mar2024 ₹1,625 Cr
47.42
Dec2023 ₹1,102 Cr
3.62
Sep2023 ₹1,064 Cr
-29.32
Jun2023 ₹1,505 Cr
19.89
Mar2023 ₹1,256 Cr -
Operating Margins
Q-o-Q

-2.63 %

Y-o-Y

7.60 %

Quarters Operating Margin% % Change
Dec2024 26.33%
-2.63
Sep2024 27.04%
-19.45
Jun2024 33.57%
14.30
Mar2024 29.37%
20.02
Dec2023 24.47%
0.49
Sep2023 24.35%
-16.87
Jun2023 29.29%
16.88
Mar2023 25.06% -

ZYDUS LIFESCIENCES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

11.90 %

Y-o-Y

41.15 %

Quarters Profit After Tax % Change
Dec2024 ₹1,005 Cr
11.90
Sep2024 ₹898 Cr
-38.66
Jun2024 ₹1,464 Cr
19.40
Mar2024 ₹1,226 Cr
72.24
Dec2023 ₹712 Cr
-8.85
Sep2023 ₹781 Cr
-29.85
Jun2023 ₹1,113 Cr
219.31
Mar2023 ₹349 Cr -
PAT Margins
Q-o-Q

11.26 %

Y-o-Y

20.70 %

Quarters PAT Margin(%) % Change
Dec2024 19.07 %
11.26
Sep2024 17.14 %
-27.31
Jun2024 23.58 %
6.46
Mar2024 22.15 %
40.19
Dec2023 15.8 %
-11.58
Sep2023 17.87 %
-17.50
Jun2023 21.66 %
211.21
Mar2023 6.96 % -

ZYDUS LIFESCIENCES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

12.25 %

Y-o-Y

30.38 %

Quarters EPS % Change
Dec2024 ₹10.17
12.25
Sep2024 ₹9.06
-35.79
Jun2024 ₹14.11
20.09
Mar2024 ₹11.75
50.64
Dec2023 ₹7.8
-1.39
Sep2023 ₹7.91
-26.35
Jun2023 ₹10.74
266.55
Mar2023 ₹2.93 -

You may also like the below Video Courses